In summary, this study contributes valuable insights into the presence, frequency, and prognostic implications of diverse PAX5 alterations in B-ALL patients, underscoring the complex interplay of genetic factors and their impact on patient prognosis. The gene discussed is PAX5; the disease is acute lymphoblastic leukemia.